BeStock  
Stocks › Biotechnology › MIRM

Mirum Pharmaceuticals MIRM

US equityMarket cap rank #1818Biotechnology
$96.13 +$0.62 (+0.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $96.13 0.00%
Open$94.50
Prev close$95.51
Day range$94.10 – $98.39
Volume1.06M
Market cap$6.28B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.5x
CheapRich

Above its usual level · 80th percentile, 5-year average -27.0x

Price / book-113.2x
CheapRich

Near the bottom of its 5-year range · 5th percentile, 5-year average -20.2x

Price / sales9.1x
CheapRich

Around its usual level · 43rd percentile, 5-year average 13.1x

#4441 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-224x-138x-53x33xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$106.56
Price vs. fair value-9.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -113.24 – -20.18 5% (cheaper than usual) –
PE -6.50 -40.76 -26.98 80% (pricier than usual) –
PS 9.15 7.45 13.12 43% (cheaper than usual) #4441 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on MIRM.

Sign in to join the discussion.

Scroll to Top